Both acute GVHD and intestinal cryptosporidial infection cause persistent diarrhea in allogeneic transplant recipients. Differentiating one from the other from the coexistence of both GVHD and cryptosporidial infection remains problematic. As shown in this case, PCR for cryptosporidium allows more accurate diagnosis than microscopic examination of stool and histology of mucosal biopsies.
A 46-year-old woman with follicular lymphoma underwent allogeneic hematopoietic SCT from an HLA-mismatched unrelated donor following reduced-intensity conditioning. GVHD prophylaxis was tacrolimus and mycophenolate mofetil. Her early post-transplant course was complicated by GVHD of the skin and gut that responded to treatment; nodal EBV negative, lymphoproliferative disorder at day 100 (treated with reduction in immune suppression and rituximab) and cerebral toxoplasmosis at day 180 (treated successfully). However, diarrhea then reappeared, with mucosal histology showing GVHD, symptoms resolved after restarting oral beclomethasone dipropionate and tacrolimus. Microbiological screening of diarrheal stools revealed no enteric viruses, fungi, bacterial pathogens or parasites (by microscopic examination). At day 300, diarrhea reappeared, with gastric and colon mucosal biopsy showing GVHD, treated by continuing tacrolimus and adding methyl prednisolone 1 mg/kg per day. Symptoms responded only partially, and continuous prednisolone was needed to control diarrhea. At day 360, diarrhea volumes increased to 42 L per day, and the patient developed nausea and abdominal pain. Stool studies revealed rotavirus and Campylobacter jejuni, with persistent symptoms despite erythromycin therapy. At day 420, repeat endoscopy showed histology consistent with GVHD, treated with oral beclomethasone dipropionate and budesonide plus i.v. rituximab and pentostatin, without response. At day 480, persistent diarrhea and pain prompted another endoscopy, with histology suggesting both infection and GVHD (Figure 1 ). There were spherical structures consistent with cryptosporidia on the surface of epithelial cells from both stomach and duodenum, best seen with Giemsa stain, along with apoptotic bodies, crypt cell dropout and inflammation. Review of past biopsies revealed the same spherical organisms starting with the day-300 mucosal biopsy. The patient then developed epigastric pain, biliary obstruction and cholestasis consistent with biliary cryptosporidial infection that required sphincterotomy and stent placement. Samples from gastric and duodenal mucosa, bile and diarrheal stool were positive for cryptosporidia by both direct fluorescent-Ab assay (Cryptocell, Cellabs, Australia) and PCR 1,2 despite negative modified Ziehl-Neelsen stains (National Center of Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain). The analysis of genotype and subtype (PCR-restriction-fragment length polymorphism COWP gene 1,2 and sequence analysis of gp60 gene 3 ) characterized the isolate as Cryptosporidium parvum, subtype IIaA21G1R1. Despite tapering systemic prednisolone (but continuing tacrolimus and oral beclomethasone dipropionate) and treatment with paromomycin 2 g per day for 2 weeks, diarrhea persisted for 5 months, when volumes increased and fever developed. At day 630 Cryptosporidium-specific PCR was positive in gastric, intestinal and bile samples, and the patient began nitazoxanide therapy for 2 weeks with complete clinical response and 10 kg body weight gain with PCR for cryptosporidia now negative. At that time she was on minimal immunosuppressive therapy with low-dose tacrolimus.
CD4 lymphocyte counts were determined several times between days 210 and 500, and they were always over 250 CD4 per mL; in fact, since day 510, CD4 counts were over 500 mL
À1
, suggesting that other factors contributed to the infections in our patient.
Months after all samples were negative for cryprosporidia by PCR, self-limited diarrhea reappeared, the biopsy was compatible with GVHD and cryptosporidia study was negative. The patient responded to low-dose glucocorticoids. At 34 months after the transplant, the patient's lymphoma remains in CR and she is free of diarrhea.
Intestinal cryptosporidial infection causes self-limited diarrhea in normal people and persistent diarrhea in immune-suppressed patients, including those who have received allogeneic hematopoietic cell transplants. Several lessons about diagnosis and treatment can be learned from the case reported here:
(1) Microscopic examination of stool specimens and histological evaluation of mucosal biopsies appear to be insensitive compared to PCR diagnosis. Although miniscule organisms can be seen attached to epithelial cells in well-prepared 4 mm tissue sections, the findings can be extremely subtle, evinced by the fact that human cryptosporidial infection was not recognized by experienced pathologists until 1976. 4, 5 (2) Cryptosporidial infection can coexist with GVHD, but may also produce inflammation and apoptotic epithelial cells that can be mistaken for GVHD. 6 The histological hallmark of gastrointestinal GVHD is apoptotic epithelial cells, most readily found at the base of crypts. 7 However, apoptotic epithelial cells are not specific for GVHD, as they can be found in most inflammatory disorders of gut mucosa. In our case, we speculate that the primary cause of severe diarrhea after day 300 post transplant was cryptosporidia infection. In retrospect, reviewing pathology anatomy since day 300, coccidian microorganism were present in mucosal biopsy specimens from day 300 until their clearance, and the patient improved only after specific treatment and tapering of immunosuppressive drugs. (3) Resolution of infection in immune-suppressed patients requires the restoration of mucosal immunity, usually achieved by discontinuation of immunosuppressive drugs; conversely, persistence of severe immune deficiency yields persistent infection, best exemplified in patients with HIV-AIDS (depending on CD4 counts). 8 Interestingly, CD4 counts in our patient were always 4250 mL
, suggesting that other factors, including underlying lymphoma, slow restoration of immunity after transplant, rituximab and other immunosuppressive drugs for GVHD, caused this severe infection in our patient. Antimicrobial therapy (paromomycin, nitazoxanide) can reduce the burden of organisms, but the aim should be immunosuppression withdrawal, as far as patient status permits. (4) Tracing the source of cryptosporidia may be important in preventing reinfection, as this infection can be acquired from water sources and as a zoonosis. Cryptosporidium parvum, subtype IIaA21G1R1, is usually of zoonotic origin from calves but it occurs only rarely in humans. 
